Two people reviewing printed graphs and charts on a table, one is holding a pen and the other is touching the paper, black and white photo.

HOYA empowers clients to navigate complex preclinical and commercial challenges with solutions tailored to each client, Accelerating research and facilitating swift access to innovative treatments for patients.

Discover How We Can Help ↓

Our Expertise, Your Success

Therapy Translation

From Lab to Clinic – Streamlining the path for your innovative therapies.

Research and Collaboration

Building Strategic Partnerships – Connecting you with the right experts and resources.

Financing and Growth

Securing Your Future – Navigating investment and expansion opportunities.

Read More

Unlock Global Expertise

We connect you with a curated network of leading experts to deliver tailored solutions for your unique challenges and accelerate the development of groundbreaking therapies.

FEATURED

Australia Cell & Gene Therapy Landscape

Cover slide for a report titled 'Australia Cell and Gene Therapy Landscape,' 2024. The report covers landscape mapping of cell and gene therapy in Australia, including areas such as CGT development, GMP manufacturing, clinical trials, and regional activities. The principal consultant, Heather Main, is credited.

Landscape mapping of Cell & Gene Therapy developers, GMP manufacturers, Clinical Trials and Regional Activities. First of its kind.

Client: Melbourne University, Australia

Year 2024

Read More

Visual Highlights

Bar chart showing recruitment and activity in clinical trials in Australia, with blue bars representing active and recruiting trials and red bars representing active and non-recruiting trials across four phases, highlighting a decrease in recruitment from Phase II to Phase IV.
A pie chart compares clinical trials of advanced therapies in Australia by gender. The chart shows 87% of trials are for both males and females (blue), and 13% are male-only trials (red). A bar graph lists the number of trials for male-exclusive conditions: cerebral 1, Fabry disease 2, prostate cancer 3, muscular dystrophy 3, and hemophilia A/B 12. Text explains most trials study X-linked disorders affecting males, with no trials exclusively for ovarian or female-only reproductive disorders. The source is HOYA, University of Melbourne, Australia CGT Landscape 2024.
...THROUGH OUR MAPPING WE AIM TO GUIDE STAKEHOLDERS—RESEARCHERS, INDUSTRY LEADERS, FUNDERS AND POLICY-MAKERS—TOWARD A MORE INFORMED AND INCLUSIVE ECOSYSTEM THAT BUILDS ON EACH OTHERS STRENGTHS FOR THE BEST PATIENT OUTCOMES.
— Heather main, Principal Consultant & Cofounder
More insights

EXPERT REPORTS

Ready to purchase reports that will aid you in navigating critical milestones in translating research to broad-patient therapies. Get your copy today.

Cover page of a report titled 'Global Analysis of GMP hPSC Start Material.' It has a dark green to black gradient background with a red banner in the top right corner that says 'SPECIAL OFFER.' The report is prepared by Heather Main, Principal Consultant and Cofounder, and includes topics like derivation technology, IP licensing, donor eligibility, clinical trial approvals, and quality assessment of raw materials and manufacturing processes.
Cover page of a report titled 'Global iPSC Patent Landscape Analysis Report 2024', with details about programming, delivery vehicles, and cell source, prepared by Heather Main and Ajdin Jakupovic.
Find out more

“In our academic hPSC-ATMP journey, we started in clinical translation and then, through partnering, gained Commercial thinking. We appreciate the type of work HOYA is doing to link academics with the competencies needed to maximise the potential for patient access.

Malin Parmar, Professor at Lund University | STEM-PD stem cell therapy program

A woman with short blonde hair, smiling, dressed in a gray blazer and dark blouse, standing in an indoor setting with blurred background.

Selected Clients

The logo of the University of Melbourne featuring a shield with an angel holding a branch, stars, and a banner with Latin phrase 'Postera Crescam Laude', with the university's name beneath.
Logo of Karlinska Institute featuring a circle with a caduceus, a cup, and a rooster, with the text 'Karlinska Institutet' and 'ARKÖLINSKA INSTITUTET' and the year '1810'.
Logo with a blue and green abstract globe design, with the text 'CCRM NORDIC' in white
Queensland Government logo featuring a shield with a bird and a kangaroo, surrounded by a crest with a crown on top, and the motto 'AUDAX AT FUDEIS' beneath.

Upcoming Events

Nordic Life Science Days

Gothenburg, Sweden

Information

9th Annual meeting of the Belgian Society for Stem Cell Research

Brussels, Belgium

Information

Engineering Stem Cells and Stem Cell Niches

Hillerød, Denmark

Information

ATMP Sweden Conference 2025

Gothenburg, Sweden

Information

Contact us.

hello@hoyaconsulting.se

Hagaplan 4, “Forskaren”
Stockholm, 133 68, Sweden